Viewing data from:

Not in the current Orange Book— This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.

CISATRACURIUM BESYLATE

ANDANot in Orange Book

CISATRACURIUM BESYLATE | A209334 | HENGRUI PHARMA

API Supply Chain10 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

GLAND PHARMA LTDCISATRACURIUM BESYLATE

DMF 229622009

TAPI NL BVCISATRACURIUM BESYLATE

DMF 231302009

WAVELENGTH ENTERPRISES LTDCISATRACURIUM BESYLATE

DMF 235542010

CF PHARMA LTDCISATRACURIUM BESYLATE VERSION FA1

DMF 249022012

CF PHARMA LTDCISATRACURIUM BESYLATE

DMF 249692012

FARMHISPANIA SACISATRACURIUM BESYLATE USP

DMF 249992011

JIANGSU HENGRUI PHARMACEUTICALS CO LTDCISATRACURIUM BESYLATE, USP, NON-STERILE, BULK DRUG SUBSTANCE

DMF 255112011

GLAND PHARMA LTDCISATRACURIUM BESYLATE [PROCESS-II]

DMF 297382015

WAVELENGTH ENTERPRISES LTDCISATRACURIUM BESYLATE PROCESS B

DMF 391232024

NAVINTA LLCCISATRACURIUM BESYLATE USP

DMF 416042025

ALP PHARM BEIJING CO LTDInactiveCISATRACURIUM BESYLATE

DMF 240332010

ON DEMAND PHARMACEUTICALS INCInactiveCISATRACURIUM BESYLATE

DMF 405932025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 2MG BASE/ML

▴

INJECTABLE;INJECTION | Approved: Aug. 30, 2017

No patent or exclusivity listings for this strength.